Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype

Experimental Gerontology

Volumn 82, Issue , 2016, Pages 39-49

  Malaquin, Nicolas ^a   Martinez, Aurélie ^a   Rodier, Francis ^a,b  

^a Institut du Cancer de Montreal   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Epigenetics; Intracellular signalling pathways; Nuclear factor kappa B; Senescence messaging secretome; Signal transduction; Signalling cascade

Indexed keywords

ALARMIN; ATM PROTEIN; CCAAT ENHANCER BINDING PROTEIN BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; TRANSCRIPTION FACTOR; CYTOKINE;

AUTOPHAGY; CELL SURVIVAL; CHROMATIN; DNA DAMAGE; EPIGENETICS; GENETIC TRANSCRIPTION; HUMAN; INFLAMMATION; METABOLIC REGULATION; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RNA STABILITY; RNA TRANSLATION; SECRETION (PROCESS); SECRETOME; SENESCENCE; SENESCENCE ASSOCIATED SECRETORY PHENOTYPE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; AGING; CELL AGING; GENETIC EPIGENESIS; GENETICS; METABOLISM; NEOPLASM;

AGING; CELL AGING; CYTOKINES; DNA DAMAGE; EPIGENESIS, GENETIC; HUMANS; NEOPLASMS; NF-KAPPA B; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 84979633299     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2016.05.010     Document Type: Review

References (153)

1. Acosta, J.C., O'Loghlen, A., Banito, A., Guijarro, M.V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., Takatsu, Y., Melamed, J., d'Adda di Fagagna, F., Bernard, D., Hernando, E., Gil, J., Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133 (2008), 1006–1018.
2. Acosta, J.C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J.P., Athineos, D., Kang, T.W., Lasitschka, F., Andrulis, M., Pascual, G., Morris, K.J., Khan, S., Jin, H., Dharmalingam, G., Snijders, A.P., Carroll, T., Capper, D., Pritchard, C., Inman, G.J., Longerich, T., Sansom, O.J., Benitah, S.A., Zender, L., Gil, J., A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat. Cell Biol. 15 (2013), 978–990.
3. Acosta, J.C., Snijders, A.P., Gil, J., Unbiased characterization of the senescence-associated secretome using SILAC-based quantitative proteomics. Methods Mol Biol. 965 (2013), 175–184.
4. Alspach, E., Flanagan, K.C., Luo, X., Ruhland, M.K., Huang, H., Pazolli, E., Donlin, M.J., Marsh, T., Piwnica-Worms, D., Monahan, J., Novack, D.V., McAllister, S.S., Stewart, S.A., p38MAPK plays a crucial role in stromal-mediated tumorigenesis. Cancer Discov. 4 (2014), 716–729.
5. Apte, R.N., Dotan, S., Elkabets, M., White, M.R., Reich, E., Carmi, Y., Song, X., Dvozkin, T., Krelin, Y., Voronov, E., The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev. 25 (2006), 387–408.
6. Armstrong, A.J., Netto, G.J., Rudek, M.A., Halabi, S., Wood, D.P., Creel, P.A., Mundy, K., Davis, S.L., Wang, T., Albadine, R., Schultz, L., Partin, A.W., Jimeno, A., Fedor, H., Febbo, P.G., George, D.J., Gurganus, R., De Marzo, A.M., Carducci, M.A., A pharmacodynamic study of rapamycin in men with intermediate- to high-risk localized prostate cancer. Clin. Cancer Res. 16 (2010), 3057–3066.
7. Asaithamby, A., Chen, D.J., Cellular responses to DNA double-strand breaks after low-dose gamma-irradiation. Nucleic Acids Res. 37 (2009), 3912–3923.
8. Baker, D.J., Sedivy, J.M., Probing the depths of cellular senescence. J. Cell Biol. 202 (2013), 11–13.
9. Baker, D.J., Perez-Terzic, C., Jin, F., Pitel, K.S., Niederlander, N.J., Jeganathan, K., Yamada, S., Reyes, S., Rowe, L., Hiddinga, H.J., Eberhardt, N.L., Terzic, A., van Deursen, J.M., Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency. Nat. Cell Biol. 10 (2008), 825–836.
10. Baker, D.J., Wijshake, T., Tchkonia, T., LeBrasseur, N.K., Childs, B.G., van de Sluis, B., Kirkland, J.L., van Deursen, J.M., Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479 (2011), 232–236.
11. Baker, D.J., Childs, B.G., Durik, M., Wijers, M.E., Sieben, C.J., Zhong, J., Saltness, R.A., Jeganathan, K.B., Verzosa, G.C., Pezeshki, A., Khazaie, K., Miller, J.D., van Deursen, J.M., Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530 (2016), 184–189.
12. Bakkenist, C.J., Kastan, M.B., DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421 (2003), 499–506.
13. Bartek, J., Lukas, J., DNA damage checkpoints: from initiation to recovery or adaptation. Curr. Opin. Cell Biol. 19 (2007), 238–245.
14. Bavik, C., Coleman, I., Dean, J.P., Knudsen, B., Plymate, S., Nelson, P.S., The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res. 66 (2006), 794–802.
15. Beausejour, C.M., Krtolica, A., Galimi, F., Narita, M., Lowe, S.W., Yaswen, P., Campisi, J., Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 22 (2003), 4212–4222.
16. Beyaert, R., Cuenda, A., Vanden Berghe, W., Plaisance, S., Lee, J.C., Haegeman, G., Cohen, P., Fiers, W., The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 15 (1996), 1914–1923.
17. Bhaumik, D., Scott, G.K., Schokrpur, S., Patil, C.K., Orjalo, A.V., Rodier, F., Lithgow, G.J., Campisi, J., MicroRNAs miR-146a/b negatively modulate the senescence-associated inflammatory mediators IL-6 and IL-8. Aging (Albany NY) 1 (2009), 402–411.
18. Bonner, W.M., Redon, C.E., Dickey, J.S., Nakamura, A.J., Sedelnikova, O.A., Solier, S., Pommier, Y., GammaH2AX and cancer. Nat. Rev. Cancer 8 (2008), 957–967.
19. Bork, S., Pfister, S., Witt, H., Horn, P., Korn, B., Ho, A.D., Wagner, W., DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 9 (2010), 54–63.
20. Brunet, A., Sweeney, L.B., Sturgill, J.F., Chua, K.F., Greer, P.L., Lin, Y., Tran, H., Ross, S.E., Mostoslavsky, R., Cohen, H.Y., Hu, L.S., Cheng, H.L., Jedrychowski, M.P., Gygi, S.P., Sinclair, D.A., Alt, F.W., Greenberg, M.E., Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303 (2004), 2011–2015.
21. Bulavin, D.V., Saito, S., Hollander, M.C., Sakaguchi, K., Anderson, C.W., Appella, E., Fornace, A.J. Jr., Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J. 18 (1999), 6845–6854.
22. Burd, C.E., Sorrentino, J.A., Clark, K.S., Darr, D.B., Krishnamurthy, J., Deal, A.M., Bardeesy, N., Castrillon, D.H., Beach, D.H., Sharpless, N.E., Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model. Cell 152 (2013), 340–351.
23. Campisi, J., d'Adda di Fagagna, F., Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8 (2007), 729–740.
24. Chandra, T., Kirschner, K., Thuret, J.Y., Pope, B.D., Ryba, T., Newman, S., Ahmed, K., Samarajiwa, S.A., Salama, R., Carroll, T., Stark, R., Janky, R., Narita, M., Xue, L., Chicas, A., Nunez, S., Janknecht, R., Hayashi-Takanaka, Y., Wilson, M.D., Marshall, A., Odom, D.T., Babu, M.M., Bazett-Jones, D.P., Tavare, S., Edwards, P.A., Lowe, S.W., Kimura, H., Gilbert, D.M., Narita, M., Independence of repressive histone marks and chromatin compaction during senescent heterochromatic layer formation. Mol. Cell 47 (2012), 203–214.
25. Chang, B.D., Broude, E.V., Dokmanovic, M., Zhu, H., Ruth, A., Xuan, Y., Kandel, E.S., Lausch, E., Christov, K., Roninson, I.B., A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res. 59 (1999), 3761–3767.
26. Chang, J., Wang, Y., Shao, L., Laberge, R.M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N.E., Ding, S., Feng, W., Luo, Y., Wang, X., Aykin-Burns, N., Krager, K., Ponnappan, U., Hauer-Jensen, M., Meng, A., Zhou, D., Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat. Med. 22 (2016), 78–83.
27. Chen, H., Ruiz, P.D., McKimpson, W.M., Novikov, L., Kitsis, R.N., Gamble, M.J., MacroH2A1 and ATM play opposing roles in paracrine senescence and the senescence-associated secretory phenotype. Mol. Cell 59 (2015), 719–731.
28. Cheng, S., Rodier, F., Manipulating senescence in health and disease: emerging tools. Cell Cycle 14 (2015), 1613–1614.
29. Chien, Y., Scuoppo, C., Wang, X., Fang, X., Balgley, B., Bolden, J.E., Premsrirut, P., Luo, W., Chicas, A., Lee, C.S., Kogan, S.C., Lowe, S.W., Control of the senescence-associated secretory phenotype by NF-kappaB promotes senescence and enhances chemosensitivity. Genes Dev. 25 (2011), 2125–2136.
30. Christophorou, M.A., Ringshausen, I., Finch, A.J., Swigart, L.B., Evan, G.I., The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature 443 (2006), 214–217.
31. Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A.J., Barradas, M., Benguria, A., Zaballos, A., Flores, J.M., Barbacid, M., Beach, D., Serrano, M., Tumour biology: senescence in premalignant tumours. Nature, 436, 2005, 642.
32. Coppe, J.P., Patil, C.K., Rodier, F., Sun, Y., Munoz, D.P., Goldstein, J., Nelson, P.S., Desprez, P.Y., Campisi, J., Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6 (2008), 2853–2868.
33. Coppe, J.P., Desprez, P.Y., Krtolica, A., Campisi, J., The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5 (2010), 99–118.
34. Coppe, J.P., Patil, C.K., Rodier, F., Krtolica, A., Beausejour, C.M., Parrinello, S., Hodgson, J.G., Chin, K., Desprez, P.Y., Campisi, J., A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. PLoS One, 5, 2010.
35. Coppe, J.P., Rodier, F., Patil, C.K., Freund, A., Desprez, P.Y., Campisi, J., Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype. J. Biol. Chem. 286 (2011), 36396–36403.
36. Cuenda, A., Rousseau, S., p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim. Biophys. Acta 1773 (2007), 1358–1375.
37. d'Adda di Fagagna, F., Reaper, P.M., Clay-Farrace, L., Fiegler, H., Carr, P., Von Zglinicki, T., Saretzki, G., Carter, N.P., Jackson, S.P., A DNA damage checkpoint response in telomere-initiated senescence. Nature 426 (2003), 194–198.
38. Davalos, A.R., Kawahara, M., Malhotra, G.K., Schaum, N., Huang, J., Ved, U., Beausejour, C.M., Coppe, J.P., Rodier, F., Campisi, J., p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes. J. Cell Biol. 201 (2013), 613–629.
39. Demaria, M., Ohtani, N., Youssef, S.A., Rodier, F., Toussaint, W., Mitchell, J.R., Laberge, R.M., Vijg, J., Van Steeg, H., Dolle, M.E., Hoeijmakers, J.H., de Bruin, A., Hara, E., Campisi, J., An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev. Cell 31 (2014), 722–733.
40. Di Leonardo, A., Linke, S.P., Clarkin, K., Wahl, G.M., DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8 (1994), 2540–2551.
41. Dimauro, T., David, G., Chromatin modifications: the driving force of senescence and aging?. Aging (Albany NY) 1 (2009), 182–190.
42. Dimri, G.P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E.E., Linskens, M., Rubelj, I., Pereira-Smith, O., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U. S. A. 92 (1995), 9363–9367.
43. Dorr, J.R., Yu, Y., Milanovic, M., Beuster, G., Zasada, C., Dabritz, J.H., Lisec, J., Lenze, D., Gerhardt, A., Schleicher, K., Kratzat, S., Purfurst, B., Walenta, S., Mueller-Klieser, W., Graler, M., Hummel, M., Keller, U., Buck, A.K., Dorken, B., Willmitzer, L., Reimann, M., Kempa, S., Lee, S., Schmitt, C.A., Synthetic lethal metabolic targeting of cellular senescence in cancer therapy. Nature 501 (2013), 421–425.
44. Durocher, D., Jackson, S.P., DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme?. Curr. Opin. Cell Biol. 13 (2001), 225–231.
45. el-Deiry, W.S., Harper, J.W., O'Connor, P.M., Velculescu, V.E., Canman, C.E., Jackman, J., Pietenpol, J.A., Burrell, M., Hill, D.E., Wang, Y., et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54 (1994), 1169–1174.
46. Falck, J., Coates, J., Jackson, S.P., Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434 (2005), 605–611.
47. Feng, F.Y., de Bono, J.S., Rubin, M.A., Knudsen, K.E., Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function. Mol. Cell 58 (2015), 925–934.
48. Franceschi, C., Campisi, J., Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J. Gerontol. A Biol. Sci. Med. Sci. 69:Suppl. 1 (2014), S4–S9.
49. Freund, A., Orjalo, A.V., Desprez, P.Y., Campisi, J., Inflammatory networks during cellular senescence: causes and consequences. Trends Mol. Med. 16 (2010), 238–246.
50. Freund, A., Patil, C.K., Campisi, J., p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J. 30 (2011), 1536–1548.
51. Garcia-Prat, L., Martinez-Vicente, M., Perdiguero, E., Ortet, L., Rodriguez-Ubreva, J., Rebollo, E., Ruiz-Bonilla, V., Gutarra, S., Ballestar, E., Serrano, A.L., Sandri, M., Munoz-Canoves, P., Autophagy maintains stemness by preventing senescence. Nature 529 (2016), 37–42.
52. Gerland, L.M., Peyrol, S., Lallemand, C., Branche, R., Magaud, J.P., Ffrench, M., Association of increased autophagic inclusions labeled for beta-galactosidase with fibroblastic aging. Exp. Gerontol. 38 (2003), 887–895.
53. Gewirtz, D.A., Autophagy and senescence: a partnership in search of definition. Autophagy 9 (2013), 808–812.
54. Gilbert, L.A., Hemann, M.T., DNA damage-mediated induction of a chemoresistant niche. Cell 143 (2010), 355–366.
55. Giuliano, S., Cheli, Y., Ohanna, M., Bonet, C., Beuret, L., Bille, K., Loubat, A., Hofman, V., Hofman, P., Ponzio, G., Bahadoran, P., Ballotti, R., Bertolotto, C., Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas. Cancer Res. 70 (2010), 3813–3822.
56. Goldstein, J.C., Rodier, F., Garbe, J.C., Stampfer, M.R., Campisi, J., Caspase-independent cytochrome c release is a sensitive measure of low-level apoptosis in cell culture models. Aging Cell 4 (2005), 217–222.
57. Gonzalez, L.C., Ghadaouia, S., Martinez, A., Rodier, F., Premature aging/senescence in cancer cells facing therapy: good or bad?. Biogerontology, 2015.
58. Hayakawa, T., Iwai, M., Aoki, S., Takimoto, K., Maruyama, M., Maruyama, W., Motoyama, N., SIRT1 suppresses the senescence-associated secretory phenotype through epigenetic gene regulation. PLoS One, 10, 2015, e0116480.
59. Herbig, U., Jobling, W.A., Chen, B.P., Chen, D.J., Sedivy, J.M., Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol. Cell 14 (2004), 501–513.
60. Herbig, U., Ferreira, M., Condel, L., Carey, D., Sedivy, J.M., Cellular senescence in aging primates. Science, 311, 2006, 1257.
61. Herranz, N., Gallage, S., Mellone, M., Wuestefeld, T., Klotz, S., Hanley, C.J., Raguz, S., Acosta, J.C., Innes, A.J., Banito, A., Georgilis, A., Montoya, A., Wolter, K., Dharmalingam, G., Faull, P., Carroll, T., Martinez-Barbera, J.P., Cutillas, P., Reisinger, F., Heikenwalder, M., Miller, R.A., Withers, D., Zender, L., Thomas, G.J., Gil, J., mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. Nat. Cell Biol. 17 (2015), 1205–1217.
62. Huang, J., Gao, X., Li, S., Cao, Z., Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 12829–12832.
63. Hubackova, S., Krejcikova, K., Bartek, J., Hodny, Z., IL1- and TGFbeta-Nox4 signaling, oxidative stress and DNA damage response are shared features of replicative, oncogene-induced, and drug-induced paracrine ‘bystander senescence’. Aging (Albany NY) 4 (2012), 932–951.
64. Iannello, A., Thompson, T.W., Ardolino, M., Lowe, S.W., Raulet, D.H., p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells. J. Exp. Med. 210 (2013), 2057–2069.
65. Jackson, S.P., Bartek, J., The DNA-damage response in human biology and disease. Nature 461 (2009), 1071–1078.
66. Jenuwein, T., Allis, C.D., Translating the histone code. Science 293 (2001), 1074–1080.
67. Jung, C.H., Ro, S.H., Cao, J., Otto, N.M., Kim, D.H., mTOR regulation of autophagy. FEBS Lett. 584 (2010), 1287–1295.
68. Kang, T.W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., Iken, M., Vucur, M., Weiss, S., Heikenwalder, M., Khan, S., Gil, J., Bruder, D., Manns, M., Schirmacher, P., Tacke, F., Ott, M., Luedde, T., Longerich, T., Kubicka, S., Zender, L., Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479 (2011), 547–551.
69. Kang, C., Xu, Q., Martin, T.D., Li, M.Z., Demaria, M., Aron, L., Lu, T., Yankner, B.A., Campisi, J., Elledge, S.J., The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4. Science, 349, 2015 (aaa5612).
70. Karin, M., How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18 (1999), 6867–6874.
71. Kefaloyianni, E., Gaitanaki, C., Beis, I., ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts. Cell. Signal. 18 (2006), 2238–2251.
72. Kim, M.Y., Zhang, T., Kraus, W.L., Poly(ADP-ribosyl)ation by PARP-1: ‘PAR-laying’ NAD + into a nuclear signal. Genes Dev. 19 (2005), 1951–1967.
73. Kim, K.S., Seu, Y.B., Baek, S.H., Kim, M.J., Kim, K.J., Kim, J.H., Kim, J.R., Induction of cellular senescence by insulin-like growth factor binding protein-5 through a p53-dependent mechanism. Mol. Biol. Cell 18 (2007), 4543–4552.
74. Kojima, H., Kunimoto, H., Inoue, T., Nakajima, K., The STAT3-IGFBP5 axis is critical for IL-6/gp130-induced premature senescence in human fibroblasts. Cell Cycle 11 (2012), 730–739.
75. Konstantinopoulos, P.A., Ceccaldi, R., Shapiro, G.I., D'Andrea, A.D., Homologous recombination deficiency: exploiting the fundamental vulnerability of ovarian cancer. Cancer Discov. 5 (2015), 1137–1154.
76. Kortlever, R.M., Higgins, P.J., Bernards, R., Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat. Cell Biol. 8 (2006), 877–884.
77. Krizhanovsky, V., Yon, M., Dickins, R.A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., Lowe, S.W., Senescence of activated stellate cells limits liver fibrosis. Cell 134 (2008), 657–667.
78. Krtolica, A., Parrinello, S., Lockett, S., Desprez, P.Y., Campisi, J., Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 12072–12077.
79. Kuilman, T., Peeper, D.S., Senescence-messaging secretome: SMS-ing cellular stress. Nat. Rev. Cancer 9 (2009), 81–94.
80. Kuilman, T., Michaloglou, C., Vredeveld, L.C., Douma, S., van Doorn, R., Desmet, C.J., Aarden, L.A., Mooi, W.J., Peeper, D.S., Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133 (2008), 1019–1031.
81. Kuilman, T., Michaloglou, C., Mooi, W.J., Peeper, D.S., The essence of senescence. Genes Dev. 24 (2010), 2463–2479.
82. Laberge, R.M., Zhou, L., Sarantos, M.R., Rodier, F., Freund, A., de Keizer, P.L., Liu, S., Demaria, M., Cong, Y.S., Kapahi, P., Desprez, P.Y., Hughes, R.E., Campisi, J., Glucocorticoids suppress selected components of the senescence-associated secretory phenotype. Aging Cell 11 (2012), 569–578.
83. Laberge, R.M., Adler, D., DeMaria, M., Mechtouf, N., Teachenor, R., Cardin, G.B., Desprez, P.Y., Campisi, J., Rodier, F., Mitochondrial DNA damage induces apoptosis in senescent cells. Cell Death Dis., 4, 2013, e727.
84. Laberge, R.M., Sun, Y., Orjalo, A.V., Patil, C.K., Freund, A., Zhou, L., Curran, S.C., Davalos, A.R., Wilson-Edell, K.A., Liu, S., Limbad, C., Demaria, M., Li, P., Hubbard, G.B., Ikeno, Y., Javors, M., Desprez, P.Y., Benz, C.C., Kapahi, P., Nelson, P.S., Campisi, J., MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat. Cell Biol., 2015.
85. Ledermann, J.A., El-Khouly, F., PARP inhibitors in ovarian cancer: clinical evidence for informed treatment decisions. Br. J. Cancer 113:Suppl. 1 (2015), S10–S16.
86. Ledermann, J., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., Scott, C., Meier, W., Shapira-Frommer, R., Safra, T., Matei, D., Macpherson, E., Watkins, C., Carmichael, J., Matulonis, U., Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer. N. Engl. J. Med. 366 (2012), 1382–1392.
87. Lee, J.C., Laydon, J.T., McDonnell, P.C., Gallagher, T.F., Kumar, S., Green, D., McNulty, D., Blumenthal, M.J., Heys, J.R., Landvatter, S.W., et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372 (1994), 739–746.
88. Levine, B., Kroemer, G., Autophagy in the pathogenesis of disease. Cell 132 (2008), 27–42.
89. Liu, D., Hornsby, P.J., Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res. 67 (2007), 3117–3126.
90. Lopez-Otin, C., Blasco, M.A., Partridge, L., Serrano, M., Kroemer, G., The hallmarks of aging. Cell 153 (2013), 1194–1217.
91. Lowe, S.W., Ruley, H.E., Jacks, T., Housman, D.E., p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74 (1993), 957–967.
92. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A., Jacks, T., p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362 (1993), 847–849.
93. Lowe, S.W., Cepero, E., Evan, G., Intrinsic tumour suppression. Nature 432 (2004), 307–315.
94. Lujambio, A., Akkari, L., Simon, J., Grace, D., Tschaharganeh, D.F., Bolden, J.E., Zhao, Z., Thapar, V., Joyce, J.A., Krizhanovsky, V., Lowe, S.W., Non-cell-autonomous tumor suppression by p53. Cell 153 (2013), 449–460.
95. Malaquin, N., Vercamer, C., Bouali, F., Martien, S., Deruy, E., Wernert, N., Chwastyniak, M., Pinet, F., Abbadie, C., Pourtier, A., Senescent fibroblasts enhance early skin carcinogenic events via a paracrine MMP-PAR-1 axis. PLoS One, 8, 2013, e63607.
96. Malaquin, N., Carrier-Leclerc, A., Dessureault, M., Rodier, F., DDR-mediated crosstalk between DNA-damaged cells and their microenvironment. Front. Genet., 6, 2015, 94.
97. Markova, E., Schultz, N., Belyaev, I.Y., Kinetics and dose-response of residual 53BP1/gamma-H2AX foci: co-localization, relationship with DSB repair and clonogenic survival. Int. J. Radiat. Biol. 83 (2007), 319–329.
98. Martin, N., Raguz, S., Dharmalingam, G., Gil, J., Co-regulation of senescence-associated genes by oncogenic homeobox proteins and polycomb repressive complexes. Cell Cycle 12 (2013), 2194–2199.
99. McCarthy, D.A., Clark, R.R., Bartling, T.R., Trebak, M., Melendez, J.A., Redox control of the senescence regulator interleukin-1alpha and the secretory phenotype. J. Biol. Chem. 288 (2013), 32149–32159.
100. Michaloglou, C., Vredeveld, L.C., Soengas, M.S., Denoyelle, C., Kuilman, T., van der Horst, C.M., Majoor, D.M., Shay, J.W., Mooi, W.J., Peeper, D.S., BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436 (2005), 720–724.
101. Miyamoto, S., Nuclear initiated NF-kappaB signaling: NEMO and ATM take center stage. Cell Res. 21 (2011), 116–130.
102. Moiseeva, O., Deschenes-Simard, X., St-Germain, E., Igelmann, S., Huot, G., Cadar, A.E., Bourdeau, V., Pollak, M.N., Ferbeyre, G., Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-kappaB activation. Aging Cell 12 (2013), 489–498.
103. Motta, M.C., Divecha, N., Lemieux, M., Kamel, C., Chen, D., Gu, W., Bultsma, Y., McBurney, M., Guarente, L., Mammalian SIRT1 represses forkhead transcription factors. Cell 116 (2004), 551–563.
104. Munoz-Espin, D., Canamero, M., Maraver, A., Gomez-Lopez, G., Contreras, J., Murillo-Cuesta, S., Rodriguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., Serrano, M., Programmed cell senescence during mammalian embryonic development. Cell 155 (2013), 1104–1118.
105. Narita, M., Nunez, S., Heard, E., Narita, M., Lin, A.W., Hearn, S.A., Spector, D.L., Hannon, G.J., Lowe, S.W., Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113 (2003), 703–716.
106. Narita, M., Young, A.R., Arakawa, S., Samarajiwa, S.A., Nakashima, T., Yoshida, S., Hong, S., Berry, L.S., Reichelt, S., Ferreira, M., Tavare, S., Inoki, K., Shimizu, S., Narita, M., Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science 332 (2011), 966–970.
107. Nassour, J., Martien, S., Martin, N., Deruy, E., Tomellini, E., Malaquin, N., Bouali, F., Sabatier, L., Wernert, N., Pinte, S., Gilson, E., Pourtier, A., Pluquet, O., Abbadie, C., Defective DNA single-strand break repair is responsible for senescence and neoplastic escape of epithelial cells. Nat. Commun., 7, 2016, 10399.
108. Ogryzko, V.V., Hirai, T.H., Russanova, V.R., Barbie, D.A., Howard, B.H., Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol. Cell. Biol. 16 (1996), 5210–5218.
109. Ohanna, M., Giuliano, S., Bonet, C., Imbert, V., Hofman, V., Zangari, J., Bille, K., Robert, C., Bressac-de Paillerets, B., Hofman, P., Rocchi, S., Peyron, J.F., Lacour, J.P., Ballotti, R., Bertolotto, C., Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS). Genes Dev. 25 (2011), 1245–1261.
110. Orjalo, A.V., Bhaumik, D., Gengler, B.K., Scott, G.K., Campisi, J., Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 17031–17036.
111. Pahl, H.L., Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18 (1999), 6853–6866.
112. Parrinello, S., Coppe, J.P., Krtolica, A., Campisi, J., Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J. Cell Sci. 118 (2005), 485–496.
113. Pazolli, E., Alspach, E., Milczarek, A., Prior, J., Piwnica-Worms, D., Stewart, S.A., Chromatin remodeling underlies the senescence-associated secretory phenotype of tumor stromal fibroblasts that supports cancer progression. Cancer Res. 72 (2012), 2251–2261.
114. Perrigue, P.M., Silva, M.E., Warden, C.D., Feng, N.L., Reid, M.A., Mota, D.J., Joseph, L.P., Tian, Y.I., Glackin, C.A., Gutova, M., Najbauer, J., Aboody, K.S., Barish, M.E., The histone demethylase jumonji coordinates cellular senescence including secretion of neural stem cell-attracting cytokines. Mol. Cancer Res. 13 (2015), 636–650.
115. Pollak, M.N., Investigating metformin for cancer prevention and treatment: the end of the beginning. Cancer Discov. 2 (2012), 778–790.
116. Pospelova, T.V., Demidenko, Z.N., Bukreeva, E.I., Pospelov, V.A., Gudkov, A.V., Blagosklonny, M.V., Pseudo-DNA damage response in senescent cells. Cell Cycle 8 (2009), 4112–4118.
117. Puvvula, P.K., Desetty, R.D., Pineau, P., Marchio, A., Moon, A., Dejean, A., Bischof, O., Long noncoding RNA PANDA and scaffold-attachment-factor SAFA control senescence entry and exit. Nat. Commun., 5, 2014, 5323.
118. Rodier, F., Detection of the senescence-associated secretory phenotype (SASP). Methods Mol. Biol. 965 (2013), 165–173.
119. Rodier, F., Campisi, J., Four faces of cellular senescence. J. Cell Biol. 192 (2011), 547–556.
120. Rodier, F., Campisi, J., Bhaumik, D., Two faces of p53: aging and tumor suppression. Nucleic Acids Res. 35 (2007), 7475–7484.
121. Rodier, F., Coppe, J.P., Patil, C.K., Hoeijmakers, W.A., Munoz, D.P., Raza, S.R., Freund, A., Campeau, E., Davalos, A.R., Campisi, J., Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat. Cell Biol. 11 (2009), 973–979.
122. Rodier, F., Munoz, D.P., Teachenor, R., Chu, V., Le, O., Bhaumik, D., Coppe, J.P., Campeau, E., Beausejour, C.M., Kim, S.H., Davalos, A.R., Campisi, J., DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. J. Cell Sci. 124 (2011), 68–81.
123. Rogakou, E.P., Pilch, D.R., Orr, A.H., Ivanova, V.S., Bonner, W.M., DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273 (1998), 5858–5868.
124. Rossiello, F., Herbig, U., Longhese, M.P., Fumagalli, M., d'Adda di Fagagna, F., Irreparable telomeric DNA damage and persistent DDR signalling as a shared causative mechanism of cellular senescence and ageing. Curr. Opin. Genet. Dev. 26 (2014), 89–95.
125. Rothkamm, K., Lobrich, M., Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 5057–5062.
126. Rovillain, E., Mansfield, L., Caetano, C., Alvarez-Fernandez, M., Caballero, O.L., Medema, R.H., Hummerich, H., Jat, P.S., Activation of nuclear factor-kappa B signalling promotes cellular senescence. Oncogene 30 (2011), 2356–2366.
127. Salminen, A., Huuskonen, J., Ojala, J., Kauppinen, A., Kaarniranta, K., Suuronen, T., Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging. Ageing Res. Rev. 7 (2008), 83–105.
128. Salminen, A., Kauppinen, A., Kaarniranta, K., Emerging role of NF-kappaB signaling in the induction of senescence-associated secretory phenotype (SASP). Cell. Signal. 24 (2012), 835–845.
129. Schroder, K., Tschopp, J., The inflammasomes. Cell 140 (2010), 821–832.
130. Sebastian, T., Malik, R., Thomas, S., Sage, J., Johnson, P.F., C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence. EMBO J. 24 (2005), 3301–3312.
131. Seto, B., Rapamycin and mTOR: a serendipitous discovery and implications for breast cancer. Clin. Transl. Med., 1, 2012, 29.
132. Shapiro, L., Dinarello, C.A., Osmotic regulation of cytokine synthesis in vitro. Proc. Natl. Acad. Sci. U. S. A. 92 (1995), 12230–12234.
133. Shaw, A.C., Joshi, S., Greenwood, H., Panda, A., Lord, J.M., Aging of the innate immune system. Curr. Opin. Immunol. 22 (2010), 507–513.
134. Shiloh, Y., Ziv, Y., The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nat. Rev. Mol. Cell Biol. 14 (2013), 197–210.
135. Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M.C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., Keyes, W.M., Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 155 (2013), 1119–1130.
136. Sun, Y., Nelson, P.S., Molecular pathways: involving microenvironment damage responses in cancer therapy resistance. Clin. Cancer Res. 18 (2012), 4019–4025.
137. Sun, Y., Campisi, J., Higano, C., Beer, T.M., Porter, P., Coleman, I., True, L., Nelson, P.S., Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat. Med. 18 (2012), 1359–1368.
138. Takahashi, A., Imai, Y., Yamakoshi, K., Kuninaka, S., Ohtani, N., Yoshimoto, S., Hori, S., Tachibana, M., Anderton, E., Takeuchi, T., Shinkai, Y., Peters, G., Saya, H., Hara, E., DNA damage signaling triggers degradation of histone methyltransferases through APC/C(Cdh1) in senescent cells. Mol. Cell 45 (2012), 123–131.
139. Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J., Kirkland, J.L., Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J. Clin. Invest. 123 (2013), 966–972.
140. Tominaga-Yamanaka, K., Abdelmohsen, K., Martindale, J.L., Yang, X., Taub, D.D., Gorospe, M., NF90 coordinately represses the senescence-associated secretory phenotype. Aging (Albany NY) 4 (2012), 695–708.
141. van Deursen, J.M., The role of senescent cells in ageing. Nature 509 (2014), 439–446.
142. Vanden Berghe, W., Plaisance, S., Boone, E., De Bosscher, K., Schmitz, M.L., Fiers, W., Haegeman, G., p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 273 (1998), 3285–3290.
143. Vermeulen, L., De Wilde, G., Van Damme, P., Vanden Berghe, W., Haegeman, G., Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J. 22 (2003), 1313–1324.
144. Wajapeyee, N., Serra, R.W., Zhu, X., Mahalingam, M., Green, M.R., Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 132 (2008), 363–374.
145. Wilson, V.L., Jones, P.A., DNA methylation decreases in aging but not in immortal cells. Science 220 (1983), 1055–1057.
146. Wu, Z.H., Shi, Y., Tibbetts, R.S., Miyamoto, S., Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science 311 (2006), 1141–1146.
147. Xue, W., Zender, L., Miething, C., Dickins, R.A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., Lowe, S.W., Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445 (2007), 656–660.
148. Yang, J., Yu, Y., Hamrick, H.E., Duerksen-Hughes, P.J., ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responses. Carcinogenesis 24 (2003), 1571–1580.
149. Yang, G., Rosen, D.G., Zhang, Z., Bast, R.C. Jr., Mills, G.B., Colacino, J.A., Mercado-Uribe, I., Liu, J., The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 16472–16477.
150. Yeung, F., Hoberg, J.E., Ramsey, C.S., Keller, M.D., Jones, D.R., Frye, R.A., Mayo, M.W., Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23 (2004), 2369–2380.
151. Young, A.R., Narita, M., Ferreira, M., Kirschner, K., Sadaie, M., Darot, J.F., Tavare, S., Arakawa, S., Shimizu, S., Watt, F.M., Narita, M., Autophagy mediates the mitotic senescence transition. Genes Dev. 23 (2009), 798–803.
152. Zheng, H., Seit-Nebi, A., Han, X., Aslanian, A., Tat, J., Liao, R., Yates, J.R. 3rd, Sun, P., A posttranslational modification cascade involving p38, Tip60, and PRAK mediates oncogene-induced senescence. Mol. Cell 50 (2013), 699–710.
153. Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A.C., Ding, H., Giorgadze, N., Palmer, A.K., Ikeno, Y., Hubbard, G.B., Lenburg, M., O'Hara, S.P., LaRusso, N.F., Miller, J.D., Roos, C.M., Verzosa, G.C., LeBrasseur, N.K., Wren, J.D., Farr, J.N., Khosla, S., Stout, M.B., McGowan, S.J., Fuhrmann-Stroissnigg, H., Gurkar, A.U., Zhao, J., Colangelo, D., Dorronsoro, A., Ling, Y.Y., Barghouthy, A.S., Navarro, D.C., Sano, T., Robbins, P.D., Niedernhofer, L.J., Kirkland, J.L., The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell 14 (2015), 644–658.